BackNLS Pharmaceutics Ltd - Warrants (25/09/2025) Overview

NLS Pharmaceutics Ltd - Warrants (25/09/2025) Current Assets

Latest current assets for NLSPW: $1.2M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$1.16M
↓ 71.31% YoYΔ $-2.88M vs prior year quarter

Peer trimmed avg / median

Loading

NLS Pharmaceutics Ltd - Warrants (25/09/2025) Current Assets History

Loading

NLS Pharmaceutics Ltd - Warrants (25/09/2025) vs. peers: Current Assets Comparison

Loading

NLS Pharmaceutics Ltd - Warrants (25/09/2025) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NLS Pharmaceutics Ltd - Warrants (25/09/2025) (NLSPW) FAQ

As of the most recent data (June 2026), NLSPW shows a current assets of $1.2M. That compares with $4M in the prior-year period — down 71.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NLSPW's current assets is now $1.2M (was $4M) — a 71.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NLS Pharmaceutics Ltd - Warrants (25/09/2025) is outperforming or lagging.

Tracking NLSPW's current assets over time shows whether NLS Pharmaceutics Ltd - Warrants (25/09/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2M That compares with $4M in the prior-year period — down 71.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has NLS Pharmaceutics Ltd - Warrants (25/09/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $1.2M) with ownership activity and broader fundamentals.

NLS Pharmaceutics Ltd - Warrants (25/09/2025)'s current assets is $1.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.